BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9387293)

  • 1. [Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors].
    Hou Y; Wang M; Liu W
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):426-8. PubMed ID: 9387293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [c-erbB2 gene amplification in human primary epithelial ovarian cancer and its clinical significance].
    Yang H; Zhang G; Xu K
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):367-70. PubMed ID: 10921034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma (92:31-39) by Lassus et al.
    Marzano R; Orlandi G; Corrado G
    Gynecol Oncol; 2004 Nov; 95(2):416-7; author reply 417-8. PubMed ID: 15491773
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amplification of C-erB2 gene in ovarian cancer].
    Zhang GL; Zu KL; Yu SY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):401-3, 444. PubMed ID: 8001415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the research of neu proto-oncogene in ovarian cancer].
    Li G; Jiao S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):176-9. PubMed ID: 7796652
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
    Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
    Afify AM; Werness BA; Mark HF
    Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
    Qian M; Feng Y; Xu L; Zheng S; Zhou X
    Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
    Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
    Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amplification and overexpression of c-erbB2 in human breast cancer].
    Chen Y; Dong J; Li C
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):16-9. PubMed ID: 7656779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.
    Lassus H; Leminen A; Vayrynen A; Cheng G; Gustafsson JA; Isola J; Butzow R
    Gynecol Oncol; 2004 Jan; 92(1):31-9. PubMed ID: 14751135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer].
    Yin D; Zhang X; Feng Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):291-2. PubMed ID: 9206183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
    Li J; Zhong M; Song LL; Su GD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.